Exactech: Here’s What Investors Need to Know Before Earnings

Exactech (NASDAQ:EXAC) will report earnings after markets close on Tuesday, July 23rd. Exactech, Inc. develops, manufactures, markets, and sells orthopedic implant devices and related surgical instrumentation. The Company also distributes biologic materials to hospitals and physicians in the United States and overseas. Exactech’s principal products include its knee and hip replacement systems.

Here is your Cheat Sheet to Exactech Earnings:

Earnings Expectations: Analysts expect earnings of $0.25 per share on revenues of $58.68 million. Currently, the company’s P/E ratio stands at 20.93.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.22 to a profit $0.21. For the current year, the average estimate is a profit of $1.06, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how Exactech has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 162 177 190 205 224
Diluted EPS ($) 0.87 0.65 0.80 0.67 0.96

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012 Mar. 31, 2013
Revenue ($) in millions 55.19 51.27 59.25 59.30
Diluted EPS ($) 0.23 0.19 0.29 0.29

Past Performance:
Exactech has beat analyst estimates 2 times in the past four quarters. This is not consistent enough to get bullish yet.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)